Condition · ICD-10 E11.9
Type 2 Diabetes
Insulin Resistance
A metabolic disorder characterized by high blood sugar due to insulin resistance and relative insulin deficiency.
Type 2 diabetes is the most common form of diabetes, driven by insulin resistance and progressive beta-cell dysfunction. It is closely associated with obesity, physical inactivity, and genetic predisposition. Management focuses on glycemic control through lifestyle changes and medications, with metformin as the cornerstone of pharmacotherapy.
At a glance
Medications tracked
6
First-line options
Metformin, Empagliflozin, Sitagliptin
Related conditions
ObesityHypertensionHigh CholesterolDiabetic Neuropathy
First-line Related Treatments
Commonly associated primary options — verify with your clinician
Short-term / As-needed
Related options for acute or bridging use
Situational
Related options for specific presentations
Top treatments tried for Type 2 Diabetes
Community-driven data · early preview
Metformin
1,800 people tried
★★★★★4.3
Empagliflozin
1,520 people tried
★★★★★4.1
Sitagliptin
1,240 people tried
★★★★★4.0
Glipizide
960 people tried
★★★★★3.8
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.